Microwave coagulation using a perfusion microwave electrode: Preliminary experimental study using ex vivo and in vivo liver

  • Authors:
    • Hideto Umehara
    • Toshihito Seki
    • Ryosuke Inokuchi
    • Toru Tamai
    • Rinako  Kawamura
    • Toshiki Asayama
    • Kozo Ikeda
    • Kazuichi Okazaki
  • View Affiliations

  • Published online on: November 11, 2011     https://doi.org/10.3892/etm.2011.380
  • Pages: 214-220
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

To assess the coagulation capability of a perfusion microwave electrode (PME) as a key component of microwave coagulation therapy, a preliminary experimental study was performed using ex vivo and in vivo livers. For a microwave electrode, a PME was employed. Using a PME, saline was passed through the electrode and injected continuously into the target tissue. Using an ex vivo bovine liver, the range of tissue coagulation was measured for various volumes of infused saline and microwave outputs. Using an in vivo porcine liver, the efficiency of coagulation by a PME was compared with that of radiofrequency ablation (RFA) using a cool-tip needle. In an ex vivo bovine liver, the range of tissue coagulation increased as the flow rate of saline increased. In the in vivo porcine liver, the range of coagulation was similar to that found in the ex vivo bovine liver. With a PME under conditions of a microwave output of 80 W, a flow rate of 3 ml/min and irradiation time of 5 min, the range of coagulation was 44.8±2.8 mm [maximum vertical diameter: (a)] x 31.2±2.4 mm [maximum transverse diameter: (b)]. The range of RFA (cool-tip needle) at 12 min was 46.0±2.0 mm (a) x 30.2±2.0 mm (b). With only 5 min of microwave irradiation, the use of a PME enabled induction of the same range of coagulation that was obtainable by RFA for 12 min. In comparison with microwave coagulation without saline infusion, the use of a PME made it possible to extend the range of tissue coagulation to a range equal to that of RFA in a short time. Microwave coagulation using a PME may be one of the suitable tissue coagulation systems for local ablation treatment.

Introduction

Over the past two decades, owing to advances in various imaging techniques, small hepatocellular carcinomas (HCCs) have been detected (1). Percutaneous ethanol injection therapy (PEIT) (26), percutaneous microwave coagulation therapy (PMCT) (711) and percutaneous radiofrequency ablation (PRFA) (1214) are minimally invasive ablation procedures that are used to treat such small tumors at numerous institutions. PEIT, which was the first to become more widely used owing to its low cost and convenience, has certain disadvantages, including insufficient local control owing to the efflux of ethanol into the blood vessels, and the inadequate diffusion of ethanol due to the presence of a fibrous capsule or septum in tumors (5,6).

To overcome these disadvantages of PEIT, thermal ablation treatments, such as PRFA and PMCT, were developed and offered local control that is better than that of PEIT (10,13). At present, PRFA is employed more commonly for local therapy since the range of tissue coagulation achieved by a single puncture is larger with PRFA than with PMCT. Therefore, a new type of microwave electrode was designed to overcome this disadvantage of conventional PMCT. This new type of microwave electrode is a perfusion microwave electrode (PME), which continuously supplies a solution to target tissues and provides continuous and stable heat. In contrast to a conventional microwave system, this system may expand the range of coagulation.

To evaluate the coagulation capability of a PME as a key component of microwave coagulation therapy, the present preliminary experimental study was conducted.

Using an ex vivo bovine liver, the range of tissue coagulation was measured for various volumes of infused saline and microwave outputs. The efficiency of coagulation using the PME was then compared with that using an RFA electrode (cool-tip needle) in an in vivo porcine liver.

Materials and methods

Coagulation experiments on an ex vivo bovine liver and an in vivo porcine liver were conducted using the PME. The system employs a microwave generator (Microtaze AZM-520; Alfresa-Pharma, Osaka, Japan), which produces microwaves at 2450±50 MHz, to be transmitted to the electrode via a coaxial cable. During microwave irradiation, thermal coagulation is induced in the tissue by dielectric heating at the tip of the electrode. PME is 14 G in diameter and 25 cm in length. The electrode has three rectangular side holes (each measuring 1×2 mm) at a position 15 mm from the tip of the electrode. A perfusion solution flows out in three directions through these holes (Fig. 1). The solution is injected into the electrode through an injection port located near the electrode connector. Infusion is performed using a pump that permits the rate of infusion to be changed appropriately.

Coagulation of an ex vivo bovine liver

When an ex vivo bovine liver was coagulated using the PME, physiological saline was injected (isotonic sodium chloride, Physisalz-PL, 0.9% w/v sodium chloride; Fuso Pharmaceutical Industries, Osaka, Japan). The flow rate was set at 0, 1, 2, 3, 4 or 5 ml/min (n=5 for each). Saline was injected using a pump (TE-161S, Terumo, Tokyo, Japan). A flow rate of saline >6 ml/min results in an overflow that exits to the surface of the liver through the insertion line. Therefore, the upper limit of the saline flow rate was set at 5 ml/min. A physiological saline solution at room temperature (approximately 25°C) was used for infusion.

In the present study, the microwave output was set at 60 or 80 W and the microwave irradiation time at 5 min. According to the manufacturer, 5 min is optimal for obtaining the maximal coagulated area by a conventional microwave electrode. In reality, clinical microwave coagulation therapy is performed under these power levels and irradiation time in Japan.

To confirm whether the temperature sufficient for tissue coagulation was continuously maintained, the temperature of the tissue at the tip of the electrode was measured during microwave irradiation at 1-min intervals. Moreover, the temperature of the electrode at a position 5 cm from the tip was measured to confirm whether the temperature rose excessively at the shaft of the electrode.

A portable thermocouple thermometer (PTC-201; Unique Medical, Tokyo, Japan) and cannula-type temperature sensors (PTI-200; Unique Medical) were employed. The sensors were attached to the tip of the electrode and to the shaft (5 cm from the tip).

The range of tissue coagulation was measured as the maximum vertical diameter (a) and maximum transverse diameter (b) of the largest coagulated area observed in the liver sections that were cut out following microwave irradiation.

The portion showing a clear discoloration (white zone) that had been induced by microwave irradiation was judged to be a coagulated area and a vaguely discolored portion, a non-coagulated section. The range was measured for the clearly discolored section only.

Coagulation of in vivo porcine liver

Using healthy pigs, in compliance with the Guidelines for Animal Experiments of Kansai Medical University (Japan), the following protocol was prepared for this study. The protocol was approved by the Animal Experimentation Committee, Kansai Medical University. The animals were handled according to the guidelines of the National Institutes of Health (Guide for the Care and Use of Laboratory Animals, NIH publication no. 90-23, revised 1990).

For the experiment in in vivo porcine liver, live pigs weighing approximately 40 kg were used (liver weight, approximately 950 g). Under light anesthesia induced by an intramuscular injection of ketamine hydrochloride (Ketalar for intravenous injection, 200 mg; Daiichi Sankyo, Tokyo, Japan) at a dose of 500 mg, endotracheal intubation was performed (Traquilon; inner diameter 7.0 mm, outer diameter 9.3 mm; 28 Fr Terumo, Tokyo, Japan). The tube was connected to a respirator (Model 55-0715; Harvard Apparatus, MA, USA). The frequency of respiration and tidal volume were set at 20 min and 15 ml/kg, respectively. An animal anesthesia apparatus was used (SN-487; Shinano Manufacturing, Tokyo, Japan) and anesthesia was maintained with a mixture of gases (oxygen and air) and 0.5–5% isoflurane (Isoful; Dainippon Sumitomo Pharma, Osaka, Japan). Under general anesthesia, a midline incision was made in the abdomen and the liver was identified. Coagulation was performed with the aid of an SSD-3500 ultrasonic apparatus (Aloka, Tokyo, Japan). The electrode was inserted under ultrasonic guidance to avoid major blood vessels and was placed at a depth of 5 cm.

Microwave coagulation with the PME was performed with the infusion of physiological saline at an approximate temperature of 25°C at 3 ml/min, a microwave output of 80 W, and an irradiation time of 5 min. On the basis of the experiment with the ex vivo bovine liver, it was decided that the aforenoted condition was efficient for an in vivo liver study. RFA was performed using a high-current 480 kHz monopolar RF generator (CC-1-100; Radionics, Burlington, MA, USA) that was capable of a 2,000 mA (200 W) output. The electrode was equipped with a cool-tip RF system (Tyco Healthcare Japan, Tokyo), 25 cm in length, with a 3-cm tip and an outer diameter of 17 G. Under general anesthesia, paired polar plates were attached to both hindlimbs of each pig. The application of RF energy was initiated with the generator in the impedance-control mode at the maximal output that is clinically required (approximately 120 W).

RFA time was set at 5 and 12 min. RFA was conducted for 5 min to compare it with the coagulation range of microwave irradiation, also conducted for 5 min. The time recommended by the manufacturer for clinical use was 12 min.

The range of tissue coagulation was measured in specimens that had been resected immediately following coagulation by both PME and RFA (n=5 for each electrode type). The maximum vertical diameter (a) and the maximum transverse diameter (b) were measured for the largest coagulated area on the cut surface of the sections obtained from the liver where the electrode was inserted. The two methods were then compared. The portion showing a clear discoloration (white zone including the hemorrhagic rim) induced by microwave irradiation and RFA was judged to be the coagulated area in accordance with a previous report (15).

Statistical analysis

Statistical differences were identified using the parametric Student’s t-test. P<0.01 was considered to be statistically significant.

Results

Temperature measurement in the ex vivo bovine liver

As shown in Fig. 2, which displays the results of temperature measurement during microwave irradiation, the tip of the electrode maintained a temperature that was sufficient for tissue coagulation (>80°C) even when the physiological saline was injected. Meanwhile, the temperature increase in the electrode shaft was suppressed to <45°C by perfusion of physiological saline through the electrode at flow rates of 3 ml/min or greater. Measurements were not taken under the conditions of a microwave output equal to 80 W and a flow rate of 1 or 2 ml/min since coagulated and carbonized tissue that adhered to the side holes of the electrode interfered with reliable injection of physiological saline.

Range of PME coagulation in the ex vivo bovine liver

Both the maximal vertical diameter (a) and maximal transverse diameter (b) were larger at 80 W than at 60 W (P<0.05) (Fig. 3).

The range of coagulation increased when physiological saline was injected. Under conditions of a microwave output equal to 80 W with no flow, the range of tissue coagulation was 41.8±2.5 mm (a) x 25.6±2.6 mm (b). When the microwave output was 80 W and the flow rates were 3, 4 and 5 ml/min, the range of tissue coagulation was 46.4±3.0 mm (a) x 32.2±1.8 mm (b), 46.4±1.1 mm (a) x 33.0±1.4 mm (b) and 48.8±0.8 mm (a) x 33.8±1.3 mm (b), respectively.

A significant difference was observed between no flow and saline infusion (Fig. 4). However, multiple comparisons of the range of coagulation revealed no significant differences between flow rates of 3, 4 and 5 ml/min at a microwave output of 80 W (Fig. 4). Therefore, a flow rate of at least 3 ml/min was selected as the irradiation setting for coagulation in the in vivo porcine liver. Moreover, when compared with the no-flow condition, the carbonization of the tissue surrounding the electrode was suppressed significantly by injecting physiological saline (Fig. 5).

Range of coagulation in in vivo porcine liver using PME or RFA

When the in vivo porcine liver was coagulated using the PME under conditions of a microwave output of 80 W, 5 min irradiation, and a flow rate of 3 ml/min, the range of coagulation was 44.8±2.8 mm (a) x 31.2±2.4 mm (b). The range of PME coagulation was compared between the result of the experiment using the ex vivo bovine liver (microwave output, 80 W; flow rate, 3 ml/min) and that of the experiment using the in vivo porcine liver. As shown in Fig. 6, no significant difference in the range of PME coagulation was evident between the ex vivo bovine liver [46.4±3.0 mm (a) x 32.2±1.8 mm (b)] and the in vivo porcine liver.

The range of RFA for 5 min in the in vivo porcine liver was 34.6±2.4 mm (a) x 18.6±0.9 mm (b). Under 5 min treatment, both the maximal vertical diameter and maximal transverse diameter were larger with PME than RFA (Fig. 7). Conversely, the range of RFA for 12 min was 46.0±2.0 mm (a) x 30.2±2.0 mm (b). This range did not differ from that of PME coagulation under the conditions of a microwave output of 80 W, 5 min irradiation, and a flow rate of 3 ml/min (Figs. 7 and 8). In the in vivo porcine liver, the same range of coagulation obtained by RFA for 12 min could be produced by the PME over 5 min of microwave irradiation.

Discussion

The microwave tissue coagulation system developed by Tabuse has mainly been used during surgery (16,17). Subsequently, a microwave electrode for percutaneous insertion was developed by Seki et al (7) and used for ultrasonically guided percutaneous coagulation therapy for HCC (711) and metastatic liver cancer (9,11). Thereafter, laparoscopic microwave coagulation therapy under local anesthesia was reported as a minimally invasive and effective therapy for HCC that is located near the hepatic surface (18,19). Microwave coagulation therapy has come to be recognized as a reliable thermal ablation procedure for liver cancer. Shibata et al conducted a randomized controlled trial to compare the two techniques for treating small HCCs and found that PMCT and PRFA were equivalent in local therapeutic efficacy, complication rates and local recurrence rates (20). However, the range of coagulation obtained with a single electrode was smaller than that obtained by RFA, a method that was subsequently developed. This is currently the major mode for local cancer treatments (1214). In addition, various methods are being developed to increase the range of microwave coagulation (21,22). Against this background, the present study was performed to evaluate the coagulation capability of a new type of microwave electrode (a PME) and to compare the coagulation capability between the PME and RFA electrodes (cool-tip needle).

Microwave tissue coagulation is defined as a mode of thermal coagulation that uses heat from friction (dielectric heating), which is generated when polar molecules (those of water in the body) vibrate markedly in response to microwave irradiation (7,10). If a conventional electrode is used, the surrounding tissues will be coagulated due to a rise in temperature (dielectric heating) caused by microwave irradiation. However, the tissue near the electrode will be carbonized owing to a rapid rise in temperature. In this situation, the delivery of microwave energy may be attenuated by the presence of carbonized tissue or its adherence to the electrode. As a result, the range of stable heating is limited.

Therefore, in the present study, a new type of microwave electrode was designed so that physiological saline could be injected continuously through it. This electrode is known as a PME. Physiological saline was injected continuously to inhibit a rapid increase of temperature at the tip of the electrode and to prevent tissue carbonization. The attenuation of microwave energy delivered due to the presence of carbonized tissue or its adherence to the electrode is averted and the microwave energy is delivered efficiently. As a result, it is thought that the coagulation range is expanded. In addition, the temperature rise of the injected physiological saline itself, by microwave irradiation, may also be related to an increase in the coagulation range.

In actuality, the carbonization of the electrode by the surrounding tissue was significantly suppressed by injecting the physiological saline and the range of coagulation was augmented in the experiment with the ex vivo bovine liver.

During microwave irradiation, the tip of the PME maintained a temperature sufficiently high for tissue coagulation, while an excessive rise in the temperature of the electrode shaft (5 cm from the tip) was inhibited by increasing the volume of the injected physiological saline. Therefore, the risk of skin burns should be reduced by clinical application of this electrode.

In the experiment using in vivo liver, the coagulation conditions were set on the basis of results obtained in the experiment in which an ex vivo bovine liver was used. The microwave output was set at 80 W since the range of coagulation increased with an increase in the microwave output from 60 to 80 W.

When the flow rate of the physiological saline was low (1 or 2 ml/min), the injection port at the tip of the electrode was sometimes occluded by the carbonization of tissue around the tip and adherence of coagulated tissue to the electrode, interfering with the injection of physiological saline. When it exceeded 6 ml/min, it became unsuitable due to saline overflow from the insertion line. Thus, the ex vivo bovine liver was coagulated at a flow rate of a few ml of saline (3, 4 or 5 ml/min).

In reality, the range of coagulation may be augmented by injecting the physiological saline at 80 W for 5 min. However, multiple comparisons of the range of coagulation displayed no significant differences between flow rates of 3, 4 and 5 ml/min. This fact demonstrated that a flow rate of 3 ml/min was sufficient to prevent tissue carbonization or its adherence to the electrode at 80 W output for 5 min. A flow rate of at least 3 ml/min was selected as being most efficient in this study.

In the experiment using in vivo porcine liver, when the microwave output was 80 W, irradiation time was 5 min and flow rate was 3 ml/min, the range of coagulation was similar to that observed in the ex vivo bovine liver under the same conditions. This result indicates that tissue coagulation using the PME may be achieved efficiently in spite of the presence of a cooling effect caused by blood flow. This suggests that the influence of tissue blood flow on coagulation is slight when this system is used. However, this was a preliminary study. Further investigation will be required to search for the best coagulation setting for the PME, such as microwave output and irradiation time.

Since the range of coagulation obtained with a single electrode is wider using RFA than microwave coagulation therapy (MCT) using the existing electrode, RFA is widely performed at present as a local ablation therapy. In the present study, the PME and a single-needle RF electrode (cool-tip needle), which is currently used at many medical institutions, were compared for their ranges of coagulation. We confirmed that the same range of coagulation obtained by the cool-tip needle under ordinary conditions (maximum output, treatment for 12 min) may be obtained by the PME within a much shorter period (5 min). Rapid-term treatment is important in clinical applications to minimize the stress on patients and operators. Moreover, rapid-term treatment may reduce the frequency of complications. Further experimental studies under various coagulation settings (e.g., power output and irradiation time) will be necessary to determine whether the coagulation ability of PME is superior to that of RFA (cool-tip needle). Furthermore, a microwave electrode having an internally cooled shaft antenna was recently developed and used clinically (22). It was reported that the range of coagulation was 54±5 (long axis) x 36±4 mm (short axis), when the in vivo porcine liver was coagulated using the cooled shaft antenna under conditions of a microwave output of 80 W, for 5 min. Therefore, a comparison study is necessary between the PME and the cooled shaft antenna.

During clinical application, one may fear that the PME could cause cancer cell seeding since physiological saline is injected into the tumor. Because the cancerous tissue around the electrode tip coagulates immediately upon initiating microwave irradiation and the temperature of the injected physiological saline is raised markedly by the microwaves, the possibility of seeding cancer cells is thought to be low. On this point, further studies using a tumor model are required (23,24).

The HITT 106 system, an RF electrode designed to increase the range of coagulation by injecting physiological saline (at a flow rate of 38–120 ml/h) during the application of RF energy, has already been developed and used clinically (25,26), with no data presented on increased cancer cell dispersion or metastasis (27). Thus, comparison research on the PME and saline perfusion RFA systems will be necessary.

In conclusion, the PME increases the range of tissue coagulation by infusion of saline into the target tissues. In in vivo porcine liver, the same range of coagulation obtained by RFA (cool-tip needle) for 12 min may be produced with the PME by 5 min of microwave treatment. We believe that the PME produces effective treatment results in a short time and is one of the tissue coagulation systems suitable for local ablation therapy.

References

1. 

T TobeJ UchinoY EndoM OtoE OkamotoM KojiroT ShikataK TanikawaT TsuzukiR MizumotoM MitoR YamadaS AriiY HiraishiPercutaneous ethanol injection therapy for hepatocellular carcinoma: predictive factors for long-term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in JapanCancer7427722780199410.1002/1097-0142(19941115)74:10%3C2772::AID-CNCR2820741006%3E3.0.CO;2-V

2. 

S ShiinaK TagawaY NiwaT UnumaY KomatsuK YoshiuraE HamadaM TakahashiY ShiratoriA TeranoPercutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patientsAJR Am J Roentgenol16010231028199310.2214/ajr.160.5.76823787682378

3. 

K KotohH SakaiS SakamotoK KotohH SakaiS SakamotoS NakayamaM SatohI MorotomiH NawataThe effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomyAm J Gastroenterol8919419819948304302

4. 

T LivraghiA GiorgioG MarinA A SalmiI de SioL BolondiM PompiliF BrunelloS LazzaroniG TorzilliHepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injectionRadiology197101108199510.1148/radiology.197.1.75688067568806

5. 

T SekiT NonakaY KubotaT MizunoY SameshimaUltrasonically guided percutaneous ethanol injection therapy for hepatocellular carcinomaAm J Gastroenterol841400140719892479262

6. 

S ShiinaK TagawaT UnumaR TakanashiK YoshiuraY KomatsuY HataY NiwaY ShiratoriA TeranoT SugimotoPercutaneous ethanol injection therapy for hepatocellular carcinoma: a histopathologic studyCancer6815241530199110.1002/1097-0142(19911001)68:7%3C1524::AID-CNCR2820680711%3E3.0.CO;2-O1654196

7. 

T SekiM WakabayashiT NakagawaT IthoT ShiroK KuniedaM SatoS UchiyamaK InoueUltrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinomaCancer74817825199410.1002/1097-0142(19940801)74:3%3C817::AID-CNCR2820740306%3E3.0.CO;2-88039109

8. 

R MurakamiS YoshimatsuY YamashitaT MatsukawaM TakahashiK SagaraTreatment of hepatocellular carcinoma: value of percutaneous microwave coagulationAJR Am J Roentgenol16411591164199510.2214/ajr.164.5.77172247717224

9. 

M SatoY WatanabeY KashuT NakataY HamadaK KawachiSequential percutaneous microwave coagulation therapy for liver tumorAm J Surg175322324199810.1016/S0002-9610(98)00007-59568662

10. 

T SekiM WakabayashiT NakagawaM ImamuraT TamaiA NishimuraN YamashikiA OkamuraK InouePercutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapyCancer8516941702199910.1002/(SICI)1097-0142(19990415)85:8%3C1694::AID-CNCR8%3E3.0.CO;2-3

11. 

T MatsukawaY YamashitaA ArakawaT NishiharuJ UrataR MurakamiM TakahashiS YoshimatsuPercutaneous microwave coagulation therapy in liver tumors: a 3-year experienceActa Radiol3841041519979191432

12. 

S RossiF FornariL BuscariniPercutaneous ultrasound-guided radiofrequency electrocautery for the treatment of small hepatocellular carcinomaJ Intervent Radiol8971031993

13. 

T LivraghiSN GoldbergS LazzaroniF MeloniL SolbiatiGS GazelleSmall hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injectionRadiology210655661199910.1148/radiology.210.3.r99fe4065510207464

14. 

T LivraghiS GoldbergS LazzaroniF MeloniT TiIeraceL SolbiatiGS GazelleHepatocellular carcinoma: radio-frequency ablation of medium and large lesionsRadiology214761768200010.1148/radiology.214.3.r00mr0276110715043

15. 

K SugimoriA NozawaM MorimotoK ShiratoA KokawaT SaitoK NumataK TanakaExtension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge: results in a pig modelJ Vasc Interv Radiol16849856200510.1097/01.RVI.0000157780.44868.7815947049

16. 

K TabuseA new operative procedure of hepatic surgery using a microwave tissue coagulatorNihon Geka Hokan481601721979553495

17. 

K TabuseBasic knowledge of a microwave tissue coagulator and its clinical applicationsJ Hepatobiliary Pancreat Surg5165172199810.1007/s0053400500289745083

18. 

S SekiH SakaguchiH KadoyaH MorikawaD HabuS NishiguchiS ShiomiT KitadaT KurokiLaparoscopic microwave coagulation therapy for hepatocellular carcinomaEndoscopy32591597200010.1055/s-2000-901410935786

19. 

S SekiH SakaguchiS IwaiH KadoyaS KabayashiT KitadaH FujiiT TanakaFive-year survival of patients with hepatocellular carcinoma treated with laparoscopic microwave coagulation therapyEndoscopy3712201225200516329021

20. 

T ShibataY IimuroY YamamotoY MaetaniF AmetaniK ItohJ KonishiSmall hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapyRadiology223331337200210.1148/radiol.2232010775

21. 

SA ShockK MeredithTF WarnerLA SampsonAS WrightTC Winter IIIDM MahviJP FineFT Lee JrMicrowave ablation with loop antenna: in vivo porcine liver modelRadiology231143149200410.1148/radiol.231102134214990816

22. 

M KuangMD LuXY XieHX XuLQ MoGJ LiuZF XuYL ZhengJY LiangLiver cancer increased microwave delivery to ablation zone with cooled-shaft antenna - experimental and clinical studiesRadiology242914924200710.1148/radiol.242305202817229876

23. 

Y MiaoY NiS MulierJ YuI De WeverF PenninckxAL BaertG MarchalTreatment of VX2 liver tumor in rabbits with ‘Wet’ electrode mediated radio-frequency ablationEur Radiol101881942000

24. 

A Hines-PeraltaZJ LiuC HorkanS SolazzoSN GoldbergChemical tumor ablation with use of a novel multiple-tine infusion system in a canine sarcoma modelJ Vasc Interv Radiol1713511358200616517782

25. 

D SchmidtJ TrübenbachJ BriegerC KoenigH PutzhammerSH DudaCD ClaussenPL PereiraAutomated saline-enhanced radiofrequency thermal ablation: initial results in ex-vivo bovine liverAJR Am J Roentgenol180163165200310.2214/ajr.180.1.180016312490496

26. 

PL PereiraJ TrübenbachM SchenkJ SubkeS KroeberI SchaeferCT RemyD SchmidtJ BriegerCD ClaussenRadiofrequency ablation: in vivo comparison of four commercially available devices in pig liversRadiology232482490200410.1148/radiol.232203018415286318

27. 

J HänslerM FrieserV TietzD UhlkeT WissniowskiT BernatikT HothornEG HahnD StrobelPercutaneous radiofrequency ablation of liver tumors using multiple saline-perfused electrodesJ Vasc Interv Radiol18405441200717377187

Related Articles

Journal Cover

February 2012
Volume 3 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Umehara H, Seki T, Inokuchi R, Tamai T, Kawamura R, Asayama T, Ikeda K and Okazaki K: Microwave coagulation using a perfusion microwave electrode: Preliminary experimental study using ex vivo and in vivo liver. Exp Ther Med 3: 214-220, 2012
APA
Umehara, H., Seki, T., Inokuchi, R., Tamai, T., Kawamura, R., Asayama, T. ... Okazaki, K. (2012). Microwave coagulation using a perfusion microwave electrode: Preliminary experimental study using ex vivo and in vivo liver. Experimental and Therapeutic Medicine, 3, 214-220. https://doi.org/10.3892/etm.2011.380
MLA
Umehara, H., Seki, T., Inokuchi, R., Tamai, T., Kawamura, R., Asayama, T., Ikeda, K., Okazaki, K."Microwave coagulation using a perfusion microwave electrode: Preliminary experimental study using ex vivo and in vivo liver". Experimental and Therapeutic Medicine 3.2 (2012): 214-220.
Chicago
Umehara, H., Seki, T., Inokuchi, R., Tamai, T., Kawamura, R., Asayama, T., Ikeda, K., Okazaki, K."Microwave coagulation using a perfusion microwave electrode: Preliminary experimental study using ex vivo and in vivo liver". Experimental and Therapeutic Medicine 3, no. 2 (2012): 214-220. https://doi.org/10.3892/etm.2011.380